9/11/24-Medication for Perinatal Opioid Use Disorder- Part 1

Presentation Resources

• American College of Obstetrics & Gynecology. (2017). Opioid Use and Opioid Use Disorder in Pregnancy.

• Behnke, M., Smith, V. C., & Committee on Substance Abuse. (2013). Prenatal substance abuse: Short-and long-term effects on the exposed fetus. Pediatrics, peds.2012-3931. doi:10.1542/peds.2012-3931

• Center for Behavioral Health Statistics and Quality. (2017). 2016 National Survey on Drug Use and Health: Detailed tables. Substance Abuse and Mental Health Services Administration, Rockville, MD. Retrieved from

• Children and Family Futures. (2017). Collaborative values inventory. Retrieved from

• Drug-Poisoning Deaths Involving Opioid Analgesics: United States, 1999-2011.
  NCHS Data Brief, No.166, September 2014. https://www.cdc.gov/nchs/data/databriefs/db166.pdf

• Clinical Guidance for Treating Pregnant and Parenting Women with Opioid Use Disorder and Their Infants (SAMHSA)

• Ecker, J. et al. (2019). Substance use disorders in pregnancy: clinical, ethical, and research imperatives of the opioid epidemic: a report of a joint workshop of the Society for Maternal-Fetal Medicine, American College of Obstetricians and Gynecologists

• Handelsman, L., Cochrane, K.J., Aronson, M.J. et al (1967) Two New Rating Scales for Opiate Withdrawal, American Journal of Alcohol Abuse, 13, 293-308 abstract only at

• Hsu YJ, Marsteller JA, Kachur SG, Fingerhood MI. (2018). Integration of Buprenorphine Treatment with Primary Care: Comparative Effectiveness on Retention, Utilization, and Cost. Popul Health Manag. 2019 Aug;22(4):292-299. doi: 10.1089/pop.2018.0163. abstr

• Jones, H. et al. (2010). Neonatal abstinence syndrome after methadone or buprenorphine exposure. New England Journal of Medicine, 363(24), 2320- 2331.

• Jones HE, Fischer G, Heil SH, et al. Maternal Opioid Treatment: Human Experimental Research (MOTHER) – Approach, Issues, and Lessons Learned.

• Kelty, E. & Hulse, G. A Retrospective Cohort Study of Obstetric Outcomes in Opioid-

Dependent Women Treated with Implant Naltrexone, Oral Methadone or Sublingual Buprenorphine, and Non-Dependent

Controls

• Milliren, C. E., Gupta, M., Graham, D. A., Melvin, P., Jorina, M., & Ozonoff, A. (2017). Hospital variation in neonatal abstinence syndrome incidence, treatment modalities, resource use, and costs across pediatric hospitals in the United States, 2013 to 2

• Patrick, S. W., Davis, M. M., Lehmann, C. U., & Cooper, W. O. (2015). Increasing incidence and geographic distribution of neonatal abstinence syndrome: United States 2009 to 2012. Journal of Perinatology, 35(8), 650–655. doi:10.1038/jp.2015.36
  
  

• U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics. (2020). Births: Final data for 2019. National Vital Statistics Reports, 59(1). Hyattsville, MD: National Center for Health Sta

• Velez, M. L., & Jansson, L. M. (2015). Perinatal addictions: Intrauterine exposures. Textbook of Addiction Treatment: International Perspectives, 2333–2363. doi:10.1007/978-88-470-5322-9_100

• Young, J. L., & Martin, P. R. (2012). Treatment of opioid dependence in the setting of pregnancy. Psychiatric Clinics of North America, 35, 441-460.
  Abstract and Key Points only at https://www.psych.theclinics.com/article/S0193-953X(12)00025-1/pdf